EU set to fine Israeli company Teva for disparaging rival multiple sclerosis medicine, sources say
The long-running case against Teva started with EU dawn raids in 2019 that led to the opening of an investigation in 2021.
A building in Jerusalem belonging to generic drug producer Teva(photo credit: REUTERS/BAZ RATNER)Updated: